US Patent Issued to BIOMARK CANCER SYSTEMS on Aug. 4 for "Method of detecting lung cancer" (Canadian Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,699,096, issued on Aug. 4, was assigned to BIOMARK CANCER SYSTEMS INC. (Richmond, Canada).

"Method of detecting lung cancer" was invented by Rashid Bux (Vancouver, Canada) and Daniel Sitar (Winnipeg, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A biomarker panel and method for a urine test for detecting lung cancer detects a biomarker selected from the group of biomarkers consisting of DMA, C5:1, C10:1, ADMA, C5-OH, SDMA, and kynurenine, or a combination thereof."

The patent was filed on April 21, 2023, under Application No. 18/304,741.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/...